Transmembrane Protein 8B (TMEM8B) Peptide
TMEM8B
Reactivity: Human
Host: Synthetic
BP, WB, IHC
-
- Target See all TMEM8B products
- TMEM8B (Transmembrane Protein 8B (TMEM8B))
- Origin
- Human
-
Source
- Synthetic
- Application
- Blocking Peptide (BP), Western Blotting (WB), Immunohistochemistry (IHC)
- Characteristics
- This is a synthetic peptide designed for use in combination with anti-C9orf127 antibody (Catalog #: ARP42472_T100). It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
- Purification
- Purified
-
-
- Application Notes
- Each Investigator should determine their own optimal working dilution for specific applications.
- Restrictions
- For Research Use only
-
- Format
- Lyophilized
- Reconstitution
- Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
- Concentration
- 1 mg/mL
- Buffer
- Final peptide concentration is 1 mg/mL in PBS.
- Handling Advice
- Avoid repeated freeze-thaw cycles.
- Storage
- -20 °C
- Storage Comment
- For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
-
- Target
- TMEM8B (Transmembrane Protein 8B (TMEM8B))
- Background
-
The down-regulation of C9orf127 may be closely associated with tumorigenesis and metastasis of colorectal carcinoma. However, it may not contribute to the development and progression of gastric carcinoma.
Alias Symbols: MGC120460, NAG-5, NGX6, RP11-112J3.10, C9orf127
Protein Interaction Partner: EZR
Protein Size: 472 - Molecular Weight
- 52 kDa
- Gene ID
- 51754
- NCBI Accession
- NM_001042589, NP_001036054
- UniProt
- Q5TCW5
-
You are here:
